Skip to content

Distal jnjection in Carpal tunnel syndrome ; Effect of Proximal injection in treatment of Carpal tunnel syndrome ;

Comparison of the efficacy of steroid injection via proximal and distal approach on the symptoms and function in patients with mild and moderate Carpat Tunnel Syndrome

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20180804040685N1
Enrollment
32
Registered
2018-11-07
Start date
2018-09-23
Completion date
Unknown
Last updated
2021-04-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal Tunnel Syndrome. Carpal tunnel syndrome

Interventions

Intervention 1: Intervention group : Injection (40 mg Methyl prednisolone) distal to crease
All injections would be made via insulin needle (gauge 29, and length 2.1 inch). Distal method injection takes place on volar section under wrist crease (palmar) and needle entrance angle would be 5
. All injections would be made via insulin needle (gauge 29, and length 2.1 inch). proximal method injection takes place in volar section (upper part of wrist crease) and medial side of Palmaris long
while, needle entrance angle is 30-40 degrees. One and three months after the injection, patients will be reevaluated in terms of severity of symptoms and functional status (VAS- Boston questionnaires

Sponsors

Tehran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Mild to moderate CTS based on Electrodiagnostic findings Older than 18 years old

Exclusion criteria

Exclusion criteria: Severe CTS with persistent pain & numbness; Previous history of CTS injection 6 months ago; Previous history of using CTS night splint; Previous history of Carpal Tunnel Release surgery ; Corticosteroid contraindication; Corticosteroid allergy; Malignancy; Inflammation; Pregnancy; Presence of neurologic disorders; Patients who have a surgical indication;

Design outcomes

Primary

MeasureTime frame
Electrodignostic findings. Timepoint: Assessment of changes in electrodiagnostic tests at the beginning of the study (before intervention) and 3 months after steroid injection. Method of measurement: EMG-NCV machine.

Secondary

MeasureTime frame
Symptom severity. Timepoint: Beginning of the study (before intervention) and 3 months after steroid injection. Method of measurement: Visual Analogue Scale.;Functional status. Timepoint: Beginning of the study (before intervention) and 3 months after steroid injection. Method of measurement: Boston carpal tunnel questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMina Meshkini

Tehran University of Medical Sciences

meshkini83@yahoo.com+98 21 8490 2110

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026